Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-21

Clinical Trial Update: Dexmedetomidine Versus Propofol in Vitreoretinal Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Dexmedetomidine vs Propofol in vitreoretinal surgery for retinal detachment completed. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • PROPOFOL (Propofol)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Retinal Detachment | Phase 4 | Status: COMPLETED | Results posted: 2017-08-21